Neither p21WAF1 nor 14-3-3sigma prevents G2 progression to mitotic catastrophe in human colon carcinoma cells after DNA damage, but p21WAF1 induces stable G1 arrest in resulting tetraploid cells

Cancer Res. 2001 Oct 15;61(20):7660-8.

Abstract

p21WAF1 and 14-3-3sigma, which are both transcriptional products of p53, have been reported to play a role in the G2 DNA damage checkpoint in mammalian cells. Human colon carcinoma cells, isogenic except for the presence or absence of either p21WAF1 or 14-3-3sigma (T. A. Chan et al., Genes Dev., 14: 1584-1588, 2000), are useful models for analysis of the role of these proteins in checkpoint control. Here, we have examined mitotic behavior within a single cell cycle after DNA damage in these cell lines. Our results show that p21WAF1, but not 14-3-3sigma, imposes a significant G2 delay after DNA damage. After G2 delay, we found that all isogenic cells, including those competent for both p21WAF1 and 14-3-3sigma, adapt to the DNA damage checkpoint and progress into mitosis, where they undergo incomplete chromosome segregation and reenter G1 with a tetraploid DNA content. Strikingly, our results show that p21WAF1, but not 14-3-3sigma, activates a checkpoint in response to DNA damage that prevents continued cycling of the tetraploid cells that result from a mitotic catastrophe characterized by failure to complete cell division. These results demonstrate that a tetraploid DNA content is not a reliable criterion to establish that arrest occurs in G2. Also, the DNA damage checkpoint mediated by p53-dependent induction of p21WAF1 assures neither G2 arrest nor DNA repair sufficient to enable accurate chromosome segregation in human colon carcinoma cells. We conclude that p21WAF1, but not 14-3-3sigma, has a unique role in the induction of G1 arrest in tetraploid cells that results from mitotic catastrophe after DNA damage.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 14-3-3 Proteins
  • Antineoplastic Agents / pharmacology
  • Biomarkers, Tumor*
  • Colonic Neoplasms / genetics*
  • Colonic Neoplasms / pathology*
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins / physiology*
  • DNA Damage*
  • DNA, Neoplasm / drug effects
  • DNA, Neoplasm / genetics
  • DNA, Neoplasm / radiation effects
  • Doxorubicin / pharmacology
  • Etoposide / pharmacology
  • Exonucleases*
  • Exoribonucleases
  • G2 Phase / genetics
  • G2 Phase / physiology*
  • Humans
  • Microscopy, Confocal
  • Mitosis / drug effects
  • Mitosis / physiology
  • Mitosis / radiation effects
  • Mitotic Index
  • Neoplasm Proteins*
  • Nocodazole / pharmacology
  • Ploidies
  • Proteins / physiology*
  • Tumor Cells, Cultured

Substances

  • 14-3-3 Proteins
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • CDKN1A protein, human
  • Cyclin-Dependent Kinase Inhibitor p21
  • Cyclins
  • DNA, Neoplasm
  • Neoplasm Proteins
  • Proteins
  • Etoposide
  • Doxorubicin
  • Exonucleases
  • Exoribonucleases
  • SFN protein, human
  • Nocodazole